Drug Shortage Report for APIDRA

Last updated on 2021-05-12 History
Report ID 138831
Drug Identification Number 02279460
Brand name APIDRA
Common or Proper name Apidra Vial
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLULISINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-05-07
Actual start date
Estimated end date 2021-06-02
Actual end date 2021-05-11
Shortage status Resolved
Updated date 2021-05-12
Company comments Transportation delay - The transportation delay is due to the strike at the Montreal Port. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-05-12 English Compare
v7 2021-05-11 French Compare
v6 2021-05-11 English Compare
v5 2021-05-08 English Compare
v4 2021-05-06 French Compare
v3 2021-05-06 English Compare
v2 2021-05-06 French Compare
v1 2021-05-06 English Compare